Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells.

There were slight increases in the mean number of cells that failed to enter into mitosis or detached upon treatment, but these differences did not reach statistical significance ( Supplementary Figure 5d and 5e ).

also in 111,027 other papers